Olanzapine for cocaine craving and relapse prevention in 2 patients.
Longo
Lance P
LP
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016739:Behavior, Addictive / Q000188:drug therapy* / Q000523:psychology; D001569:Benzodiazepines; D019970:Cocaine-Related Disorders / Q000188:drug therapy* / Q000517:prevention & control / Q000523:psychology; D016578:Crack Cocaine / Q000009:adverse effects; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D055502:Secondary Prevention
D014150:Antipsychotic Agents; D016578:Crack Cocaine; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine